| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accountability for medical participation in torture
|
Rubenstein, Leonard
|
|
|
395 |
10240 |
p. 1827
|
article
|
| 2 |
Acute liver failure
|
Vento, Sandro
|
|
|
395 |
10240 |
p. 1833
|
article
|
| 3 |
Acute liver failure – Authors' reply
|
Stravitz, R Todd
|
|
|
395 |
10240 |
p. 1833-1834
|
article
|
| 4 |
Aspirin for Lynch syndrome: a legacy of prevention
|
Yurgelun, Matthew B
|
|
|
395 |
10240 |
p. 1817-1818
|
article
|
| 5 |
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF
V600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
|
Gutzmer, Ralf
|
|
|
395 |
10240 |
p. 1835-1844
|
article
|
| 6 |
Atrial septal defect and haemodynamic consequences of continuous positive airway pressure treatment
|
Eerdekens, Rob
|
|
|
395 |
10240 |
p. 1864
|
article
|
| 7 |
A view from UK public health registrars on the challenges of COVID-19
|
Allen, Matilda
|
|
|
395 |
10240 |
p. 1830
|
article
|
| 8 |
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
|
Burn, John
|
|
|
395 |
10240 |
p. 1855-1863
|
article
|
| 9 |
Clinical endpoint adjudication
|
Meah, Mohammed N
|
|
|
395 |
10240 |
p. 1878-1882
|
article
|
| 10 |
COVID-19 testing delays and pathology services in the UK
|
Banatvala, Jangu
|
|
|
395 |
10240 |
p. 1831
|
article
|
| 11 |
COVID-19 vaccines for all?
|
Usher, Ann Danaiya
|
|
|
395 |
10240 |
p. 1822-1823
|
article
|
| 12 |
Department of Error
|
|
|
|
395 |
10240 |
p. 1834
|
article
|
| 13 |
Department of Error
|
|
|
|
395 |
10240 |
p. 1834
|
article
|
| 14 |
Excess mortality in men and women in Massachusetts during the COVID-19 pandemic
|
Krieger, Nancy
|
|
|
395 |
10240 |
p. 1829
|
article
|
| 15 |
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
|
The Lancet Editors,
|
|
|
395 |
10240 |
p. e102
|
article
|
| 16 |
Increasing tobacco sales under the anti-smoking policy in China
|
Luo, Hailong
|
|
|
395 |
10240 |
p. 1834
|
article
|
| 17 |
Jacob Plange-Rhule
|
Green, Andrew
|
|
|
395 |
10240 |
p. 1828
|
article
|
| 18 |
Major burns: debt recovery or ethics?
|
Arkoulis, Nikolaos
|
|
|
395 |
10240 |
p. e103-e104
|
article
|
| 19 |
Medicine and medical science: Black lives must matter more
|
The Lancet,
|
|
|
395 |
10240 |
p. 1813
|
article
|
| 20 |
Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis
|
Ladhani, Shamez N
|
|
|
395 |
10240 |
p. 1865-1877
|
article
|
| 21 |
Minimise, manage, and modify: the UK must create and use time
|
Rochford, Connor
|
|
|
395 |
10240 |
p. 1829-1830
|
article
|
| 22 |
NICE guideline for rectal cancer: already out of date
|
Glynne-Jones, Robert
|
|
|
395 |
10240 |
p. e105-e106
|
article
|
| 23 |
Offline: COVID-19—what we can expect to come
|
Horton, Richard
|
|
|
395 |
10240 |
p. 1821
|
article
|
| 24 |
Questioning statin therapy for older patients
|
Abramson, John
|
|
|
395 |
10240 |
p. 1831-1832
|
article
|
| 25 |
Questioning statin therapy for older patients – Authors' reply
|
Fulcher, Jordan
|
|
|
395 |
10240 |
p. 1832-1833
|
article
|
| 26 |
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
|
Mehra, Mandeep R
|
|
|
395 |
10240 |
p. 1820
|
article
|
| 27 |
Revisiting the 1957 and 1968 influenza pandemics
|
Honigsbaum, Mark
|
|
|
395 |
10240 |
p. 1824-1826
|
article
|
| 28 |
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
|
Zhu, Feng-Cai
|
|
|
395 |
10240 |
p. 1845-1854
|
article
|
| 29 |
The starting line for COVID-19 vaccine development
|
Lee, Nelson
|
|
|
395 |
10240 |
p. 1815-1816
|
article
|
| 30 |
The WHO we want
|
Nay, Olivier
|
|
|
395 |
10240 |
p. 1818-1820
|
article
|
| 31 |
Triple therapy for BRAF
V600-mutated melanoma
|
Ribas, Antoni
|
|
|
395 |
10240 |
p. 1814-1815
|
article
|
Journal description